NASDAQ:ELVN | Cash Flow Statement | Enliven Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$32.49M$7,000.00
2026-03-31-$23.63M$14,000.00-$19.29M$42.53M$10.05M
2025-12-31-$29.67M$83,000.00-$15.84M$12.38M$623,000.00
2025-09-30-$20.15M$62,000.00
2025-06-30-$25.34M$81,000.00
2025-03-31-$28.54M$74,000.00-$24.13M$1.43M$234,000.00
2024-12-31-$23.18M$63,000.00-$17.2M$727,000.00$39.97M
2024-09-30-$23.16M$80,000.00
2024-06-30-$19.95M$79,000.00
2024-03-31-$22.74M$79,000.00-$23.36M-$17.89M$90.27M
2023-12-31-$19.37M$80,000.00-$12.48M$38.69M$90,000.00
2023-09-30-$20.77M$79,000.00
2023-06-30-$16.72M$74,000.00
2023-03-31-$14.72M$67,000.00-$20.84M-$31,000.00$237.44M
2022-12-31-$9.55M$49,000.00-$8.15M-$101,000.00-$2.38M
2022-09-30-$10.55M$60,000.00
2022-06-30-$8.89M$52,000.00
2022-03-31-$8.67M$39M-$10.36M-$194,000.00$409,000.00
2021-12-31-$14.32M-$12.49M-$14.49M-$10,000.00
2021-09-30-$13.65M
2021-06-30-$13.16M
2021-03-31-$10.26M-$13.02M$18.3M$460,000.00
2020-12-31-$11.52M-$8.27M$21.21M$597,000.00
2020-09-30-$12.42M
2020-06-30-$10.2M
2020-03-31-$7.22M-$9.53M$4.76M$86.56M
2019-12-31-$7.25M-$8.04M-$2.11M-$2M
2019-09-30-$6.62M
2019-06-30-$5.4M
2019-03-31-$4.19M-$2.41M$43.93M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$103.69M$300,000.00-$70.3M-$173.84M$218.87M
2024-12-31-$89.02M$300,000.00-$73.19M-$36M$133.17M
2023-12-31-$71.58M$300,000.00-$61.27M-$148.41M$234.29M
2022-12-31-$37.66M$200,000.00-$32.08M-$612,000.00-$1.8M
2021-12-31-$51.38M-$46.77M-$1.63M$49.1M
2020-12-31-$41.36M-$37.4M-$16.72M$96.88M
2019-12-31-$23.46M-$21.88M-$24.06M$43.58M